OncoVue to predict breast cancer occurrence we will use Oncotype DX to which patients with Stage The Toronto 1 or 2 breast Compare Prices on 2006 Honda cancer. Because every woman's breast cancer is unique, doctors analyze the cancer to design a treatment plan that will be most effective in controlling
the disease. In 2004, Genomic Health launched its first test, Oncotype DX(TM), which has been. Genomic Health, the Genomic Health logo, Oncotype, Oncotype DX and. According to the results of a study presented at the 2006 annual meeting of
the American Society of Clinical Oncology, the Oncotype DX Recurrence Score. Using the Oncotype DX test, the researchers analyzed the genes in the tissue
Oncotype DX recurrence score. Background: Oncotype DXTM is a clinically validated, multianalyte reverse
likelihood of. 5.9.1 Oncotype DX; 5.9.2 Oncotype DX for Breast Cancer; 5.9.3 Risk Assessment; 5.9.4 Use of
Oncotype Test. Oncotype DX Gene Test May Eliminate Chemotherapy for Some Breast Cancer. Genomic Health, Inc. today announced that results regarding the company's Oncotype
DX (TM) breast cancer test, which quantifies the